Small EV TDP-43 levels were also very low in a small number of FTD cases with confirmed MAPT mutations, and high in most cases with confirmed TDP-43 pathology, indicating potential as a biomarker to distinguish FTD cases by underlying tau or TDP-43 pathology. This evidence concerns the gene TARDBP and frontotemporal dementia.